These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1077787)

  • 1. Intrarenal formation of angiotensin II in the rat: interference by Saralasin and SQ 20881.
    Zschiedrich H; Hofbauer KG; Hackenthal E; Baron GD; Gross F
    Clin Sci Mol Med Suppl; 1975 Jun; 2():37s-40s. PubMed ID: 1077787
    [No Abstract]   [Full Text] [Related]  

  • 2. Saralasin and SQ 20881 : their effects on central nervous system norepinephrine.
    Martínez Seeber A; Fernández BE; Domínguez AE; Vidal NA
    Arch Int Physiol Biochim; 1978 Feb; 86(1):175-8. PubMed ID: 80175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs.
    Kimbrough HM; Vaughan ED; Carey RM; Ayers CR
    Circ Res; 1977 Feb; 40(2):174-8. PubMed ID: 191213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats.
    Jaeger P; Ferguson RK; Brunner HR; Kirchertz EJ; Gavras H
    Kidney Int; 1978 Apr; 13(4):289-96. PubMed ID: 651128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
    Stumpe KO; Kolloch RE; Redlich B; Vetter H; Krück F
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():167-76. PubMed ID: 613561
    [No Abstract]   [Full Text] [Related]  

  • 6. Time course of changes in plasma renin after blockade of the renin-system. Studies of conscious and anaesthetized, normal, adrenalectomized and spontaneously hypertensive rats.
    Bing J; Poulsen K
    Acta Pathol Microbiol Scand A; 1975 Sep; 83(5):454-66. PubMed ID: 170788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of renin release and intrarenal formation of angiotensin. Studies in the isolated perfused rat kidney.
    Hofbauer KG; Zschiedrich H; Gross F
    Clin Exp Pharmacol Physiol; 1976; 3(1):73-93. PubMed ID: 985607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
    Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of angiotensin II formation in the CNS in angiostensin I - elicited thirst.
    Casner PR; Goldman HW; Lehr D
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):39-51. PubMed ID: 935653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II.
    Hepp R; Grillet C; Peytremann A; Vallotton MB
    Prog Biochem Pharmacol; 1976; 12():41-8. PubMed ID: 1019169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
    Harris PJ; Munro JO
    J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Mechanisms in hypertension.
    Lancet; 1975 Sep; 2(7932):445. PubMed ID: 51247
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrarenal role of angiotensin II and [des-Asp1]angiotensin II.
    Hall JE; Coleman TG; Guyton AC; Balfe JW; Salgado HC
    Am J Physiol; 1979 Mar; 236(3):F252-9. PubMed ID: 426067
    [No Abstract]   [Full Text] [Related]  

  • 15. Central hypertensive actions of angiotensin.
    Vollmer R; Buckley JP; Solomon TA; Jandhyala BS
    Acta Physiol Lat Am; 1974; 24(5):582-6. PubMed ID: 4377510
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for the local occurrence of angiotensin II in rat kidney and its modulation by dietary sodium intake and converting enzyme blockade.
    Mendelsohn FA
    Clin Sci (Lond); 1979 Aug; 57(2):173-9. PubMed ID: 477254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

  • 18. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
    Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI
    Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrarenal effects of the renin-angiotensin system.
    Ploth DW; Navar LG
    Fed Proc; 1979 Aug; 38(9):2280-5. PubMed ID: 456614
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of saralasin on renal function of the rat.
    Hofbauer KG; Bauereiss K; Zschiedrich H; Gross F
    Prog Biochem Pharmacol; 1976; 12():63-83. PubMed ID: 1019171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.